Director sold ~$267K of Jazz Pharmaceuticals
Scheduled in advanceLoading…
Traded May 28, 2026 · Filed Jun 2, 2026
Jazz Pharmaceuticals's Chief Commercial Officer sold $1.63M of Jazz Pharmaceuticals shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$1,625,977
Shares × reported transaction price
23 days after results of May 5, 2026, 67 days before results of Aug 3, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +1.4% | −3.0% | +4.3% |
| 30 days | +7.7% | −1.9% | +9.6% |
| 90 days | +10.9% | +1.0% | +9.9% |
Past results only. Not a forecast.
Director sold ~$267K of Jazz Pharmaceuticals
Scheduled in advanceOfficer sold ~$278K of Jazz Pharmaceuticals
Scheduled in advanceGift or transfer — classified separately from trades.